跳至主要内容
临床试验/PACTR202206531545729
PACTR202206531545729尚未招募未知

Integrating herbal incretin mimetics in orthodox diabetes care

Imo State University Owerri0 个研究点目标入组 108 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Year(s) 至 64 Year(s)(—)
性别
All

入选标准

  • Male or female, age = 18 years at the time of signing inform consent
  • - BMI =25 and <40 kg/m2
  • - Subjects diagnosed with T2D treated with a stable dose of metformin for at least 30 days prior to screening
  • - HbA1c 7.0-9.5% (53-80 mmol/mol) (both inclusive)

排除标准

  • - Subjects on selected oral medication with a narrow therapeutic window, such as warfarin,
  • digoxin, tricyclic antidepressants, lithium, aminophylline, theophylline and anticonvulsants
  • - History of chronic pancreatitis or idiopathic acute pancreatitis
  • - Chronic malabsorption, regardless of etiology
  • - History of Crohn’s disease, ulcerative colitis, or other inflammatory bowel disease
  • - Treatment with glucose lowering agent(s) other than metformin as stated in the inclusion criteria
  • in a period of 90 days before the screening visit.

研究者

发起方
Imo State University Owerri

相似试验